参考文献/References:
[1] Lindsey B A, Markel J E, Kleinerman E S.Osteosarcoma Overview[J].Rheumatol Ther, 2017, 4(1):25-43.
[2] Chen Z, Wu H, Wang G H, et al.Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile[J].Bmc Nephrology, 2016, 17(1):149.
[3] Gandhi M, Smith B A, Bovellan M, et al.GMF is a cofilin homolog that binds Arp2/3 complex to stimulate filament debranching and Inhibit actin nucleation[J].Curr Biol, 2010, 20(9):861-867.
[4] Lippert D N.Glia maturation factor gamma regulates the migration and adherence of human T lymphocytes[J].Bmc Immunology, 2012, 13(10):21.
[5] Aerbajinai W, Liu L, Chin K, et al.Glia maturation factor-γ mediates neutrophil chemotaxis[J].Journal of Leukocyte Biology, 2011, 90(3):529-538.
[6] Takeshi O, Yuki K, Yuichi A, et al.COXPRESdb v7: a gene coexpression database for 11 animal species supported by 23 coexpression platforms for technical evaluation and evolutionary inference[J].Nucleic Acids Research, 2019, 47(D1):D55-D62.
[7] Mahlam?ki E H, Kauraniemi P, Monni O, et al.High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer[J].Neoplasia, 2004, 6(5):432-439.
[8] Riina K, Kimmo S, Azorsa D O, et al.Intersex-like(IXL)is a cell survival regulator in pancreatic cancer with 19q13 amplification[J].Cancer Research, 2007, 67(5):1943-1949.
[9] Li Y L, Ye F, Cheng X D, et al.Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer[J].European Journal of Cancer, 2010, 46(11):2104-2118.
[10] Wang H, Chen Z, Chang H, et al.Expression of glia maturation factor γ is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro[J].Oncolog y Reports, 2017, 37(2):929-936.
[11] Szczerba B M, Castro-Giner F, Vetter M, et al.Neutrophils escort circulating tumour cells to enable cell cycle progression[J].Nature, 2019, 566(7745):553-557.
相似文献/References:
[1]肖莉莉 刘 晖 贾春锋.基于核酸适配体的微流控芯片的构建及对循环肿瘤细胞筛选性能的测定[J].福建医药杂志,2020,42(02):119.
[2]陈康尧,顾恩毅,蔡碰德,等.H1受体拮抗剂异丙嗪对顺铂治疗骨肉瘤的影响及机制[J].福建医药杂志,2021,43(04):132.
CHEN Kangyao,GU Enyi,CAI Pengde,et al.Efficacy and mechanism of H1 receptor antagonist promethazine on osteosarcoma treated with cisplatin[J].FUJIAN MEDICAL JOURNAL,2021,43(02):132.
[3]钟志辉,林焱斌,庄 研,等.骨肉瘤组织ACTN4和CD133的表达及其影响因素[J].福建医药杂志,2021,43(05):117.
ZHONG Zhihui,LIN Yanbin,ZHUANG Yan,et al.Expression and interfering factors of ACTN4 and CD133 in osteosarcoma[J].FUJIAN MEDICAL JOURNAL,2021,43(02):117.
[4]林东泽.shRNA沉默c-myc基因对MG-63骨肉瘤细胞c-myc/PD-L1轴的影响[J].福建医药杂志,2022,44(05):133.